Tag: EU
Exclude medical devices from the list of India-EU Free Trade Agreement...
India already dependent on imports of medical devices to the tune of 70% presently
OPPI welcomes Indian govt’s move to waive off local clinical trials...
This will be applicable to a few select drugs already approved in well-regulated markets like the USA, UK, Japan, Australia, Canada, and the EU
Lupin completes Phase 3 trials for Lucentis Biosimilar
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Biopharma industry’s response to EU reform proposals varies: GlobalData
Survey reveals mixed sentiments among industry leaders regarding impending EU regulatory changes
Qure.ai adds new FDA breakthrough device status to growing list of...
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Cipla enters into JV with Kemwell Biopharma & Manipal Education &...
The primary goal of this joint venture is to develop and commercialize novel Cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
BSV to set up a new biopharma manufacturing plant in Genome...
Proposed bio-pharmaceutical manufacturing facility will cater to domestic and export markets including regulated markets like USA and EU
Biocon Biologics receives European Commission approval for YESAFILI biosimilar Aflibercept
Aflibercept had EU brand sales of approximately $1.8B for the 12 months ending December 31, 2022, according to IQVIA
VAV Lipids completes expansion of high purity lipids facility
The expanded facility will produce about six times its current volume of high-grade lipid ingredients, up from about 21 kg to 120 kg per month
Takeda’s tetravalent vaccine for Dengue approved for use in European Union
Effective dengue prevention requires a multi-faceted approach, and previous methods have been insufficient for a number of reasons